Three Sources, Three Different Weights
Physiotherapists are used to being asked for the evidence behind a technique, and to saying honestly how strong it is. This page applies the same standard to Prysm iO. The sources are arranged from firmest to thinnest. Beside each one you will find who paid for it and where it falls short, which lets you decide how much weight it deserves in your own practice.
Read These Limits First
- The university research concerns earlier scanners, not Prysm iO itself.
- The blood-test comparison was paid for by the manufacturer and a university.
- The large lifestyle study is a Nu Skin report, not an independent paper, and relies on what people said about themselves.
- A reading comes with a margin of around 10 per cent, so it is a snapshot and not a verdict.
Source One: A University Review of the Method (Earlier Devices)
Measuring the carotenoids that sit in skin, as a sign of how much fruit and vegetable someone eats, was refined across a decade or more of papers. A good share came from Dr. Susan T. Mayne's group, based at Yale School of Public Health and Yale Cancer Center, who worked with University of Utah physicists. The physicists made the first instruments.
The choice of a scan was down to practicalities. A study of inner-city kids' diets would otherwise have meant graduate students going out to collect children's blood, which the team was reluctant to ask of them, and a non-invasive reading made that unnecessary.
The group summed up the field in a 2013 review for Archives of Biochemistry and Biophysics. It combined published work by others with the team's own (including a survey of 1,375 adults and a study of 381 children), and stated:
“Skin carotenoid status as assessed by RRS is an attractive biomarker for use in human studies.”
- Mayne ST, Cartmel B, Scarmo S, Jahns L, Ermakov IV, Gellermann W. “Resonance Raman spectroscopic evaluation of skin carotenoids as a biomarker of carotenoid status for human studies.” Arch Biochem Biophys. 2013;539(2):163-70. PubMed
One boundary matters here. The devices examined were earlier-generation resonance Raman spectroscopy (RRS) scanners. Prysm iO was not the subject of that review, and the review does not speak for it.
The authors also observed that when participants write down what they eat it becomes hard to know whether behaviour has genuinely changed, one reason a skin measurement appealed to them. Their view was that skin carotenoids work as a biomarker of fruit and vegetable intake, moving with supplementation and with dietary change. In the same breath they admitted that diet accounts for only some of the differences seen and that bigger studies were called for. Later scanners, Prysm iO among them, draw on this research.
Source Two: One Study Against a Blood Test
In a laboratory, this biomarker is measured with a specialised serum carotenoid blood test. Routine bloodwork does not include it, and a specialist lab may take about three weeks to return a result. Nu Skin funded a study, carried out with dermatologist Dr. Zoe Draelos, that compared the 15-second Prysm iO reading with that test in 97 volunteers.
R² = 0.77
How closely Prysm iO scores and serum carotenoid blood levels moved together, in a Nu Skin-funded study of 97 people.
Riggs M, Knaggs H, Lephart ED, Gibb T, Draelos ZD. Food & Nutrition Journal, 2026 (the paper reports R² = 0.7659 for Prysm iO). Read the paper. The study was funded by NSE Products (the maker of Prysm iO) and Brigham Young University.
For everyday field use Nu Skin quotes a margin of about ±10%. Any one reading is a snapshot; the direction of travel across repeat scans tells you more than a lone score does.
Source Three: A Large Lifestyle Study, Lightest in Weight
The third source is a Nu Skin report from Shanghai Jiao Tong University. There, 589 healthy adults had a Prysm iO scan and described their own diet, lifestyle, fitness and sleep. Those with lower scores tended to report more fried food, sugary drinks and red meat. Those with higher scores tended to report more fruit, vegetables, whole grains and freshwater fish, a balanced BMI, sleep given priority, regular exercise and limited UV exposure.
Everything here is correlation reported by Nu Skin, drawn from what people said about their diet and outcomes. No independent peer-reviewed paper has been published from the bulletin, so treat it as helpful background that weighs less than the Yale review.
Source: Nu Skin research bulletin on Prysm iO (NSE Products, 2026), principal investigator Professor Cai of Jiao Tong University. Read the bulletin (PDF). The bulletin also reports a correlation of 0.806 between Prysm iO and BioPhotonic Scanner S3 scores in the same 589 people.
Holding This Evidence Beside Your Own Practice
None of the three sources touches muscles, joints, nerves or recovery, and none set out to. They concern a wellness reading of skin carotenoids and nothing else. When a patient or colleague asks what that means for a rehabilitation programme, the honest reply is that the evidence is silent on it.
Where it could fit is a general conversation about food and daily habits: a baseline reading, perhaps repeated at a review or at discharge, or something kept entirely away from patient care and used at workplace wellbeing days, sports clubs and community events. Either way, decide in advance what you will say about the evidence, including the funding, and how you will declare your interest.
Whether and how you mention products to patients is for you to settle against your own regulator and professional body: the HCPC standards, the CSP code, and your employer, practice owner or insurer where those apply. Declare any financial interest and put the patient first. The score should never be presented as a reason to change care.
The Family Tree of the Scanner
- 1999: Pharmanex's first Biophotonic Scanner, built into a room and calibrated over roughly an hour.
- 2002: a portable model arrives, using Raman spectroscopy (the method is named after the physicist C.V. Raman and is about a century old).
- 2003, 2006, 2013: the S1, S2 and S3 go on sale. The S3 adds Bluetooth and 30-second scans, and the line eventually spans 51 countries and over 25 million scans.
Prysm iO follows as a fourth generation, and a genuinely different one. The finger replaces the palm, and the optics change as well: a patent-pending “spectral ray” method gathers hundreds of thousands of readings of the light that skin takes in and reflects, in the manner of a pulse oximeter, where Raman spectroscopy depends on an emitted signal. Prysm iO's AI-driven scoring still refers to the Raman research base, yet Raman and the 30-second scan are S3 features, not Prysm iO ones. The inheritance is the R&D of more than twenty years and the data from over 25 million scans.
Certified Products, the Money-Back Policy and Awards
Nu Skin gives some of its products a “Prysm Certified” label. Buyers of a certified, Prysm-eligible product fall under a money-back policy, which is subject to Nu Skin's Terms and Conditions. Read those terms in full before mentioning them to a patient, bearing in mind your duties around conflicts of interest.
Away from Nu Skin's own research programme, Prysm iO has collected the awards below. They honour the product and do not count as extra evidence:
- Achievement in Technology Innovation - TITAN Business Awards (winner page)
- Best of Category, Wellness Insight - Globee Business Awards
- Personal category winner - Good Design Awards 2025 (project page)
Please remember that Prysm iO is a wellness insight tool, not a medical device. Nothing about it is intended to diagnose, treat, cure or prevent any disease or medical condition, and it cannot stand in for a physiotherapy assessment, medical advice or dietetic advice.